Impact of antimalarial (AM) on serum lipids in systemic lupus erythematosus (SLE) patients: A systematic review and meta-analysis

por Tao, Chen-Yang, Shang, Jin, Chen, Tao, Yu, Dahai, Jiang, Yu-Min, Liu, Dong, Cheng, Gen-Yang, Xiao, Jing, Zhao, Zhan-Zheng
Publicado 2019

Perioperative blood transfusion does not affect recurrence-free and overall survivals after curative resection for intrahepatic cholangiocarcinoma: a propensity score matching anal...

por Zhou, Pei-Yun, Tang, Zheng, Liu, Wei-Ren, Tian, Meng-Xin, Jin, Lei, Jiang, Xi-Fei, Wang, Han, Tao, Chen-Yang, Ding, Zhen-Bin, Peng, Yuan-Fei, Qiu, Shuang-Jian, Dai, Zhi, Zhou, Jian, Fan, Jia, Shi, Ying-Hong
Publicado 2017

Prognostic Value and Predication Model of Microvascular Invasion in Patients with Intrahepatic Cholangiocarcinoma

por Tang, Zheng, Liu, Wei-Ren, Zhou, Pei-Yun, Ding, Zhen-Bin, Jiang, Xi-Fei, Wang, Han, Tian, Meng-Xin, Tao, Chen-Yang, Fang, Yuan, Qu, Wei-Feng, Dai, Zhi, Qiu, Shuang-Jian, Zhou, Jian, Fan, Jia, Shi, Ying-Hong
Publicado 2019

Surgical Treatment of Combined Hepatocellular-Cholangiocarcinoma is as Effective in Elderly Patients as it is in Younger Patients: A Propensity Score Matching Analysis

por Tao, Chen-Yang, Liu, Wei-Ren, Jin, Lei, Tang, Zheng, Tian, Meng-Xin, Jiang, Xi-Fei, Wang, Han, Zhou, Pei-Yun, Fang, Yuan, Ding, Zhen-Bin, Peng, Yuan-Fei, Dai, Zhi, Qiu, Shuang-Jian, Zhou, Jian, Fan, Jia, Shi, Ying-Hong
Publicado 2018

Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after cura...

por Liu, Wei-Ren, Tian, Meng-Xin, Tao, Chen-Yang, Tang, Zheng, Zhou, Yu-Fu, Song, Shu-Shu, Jiang, Xi-Fei, Wang, Han, Zhou, Pei-Yun, Qu, Wei-Feng, Fang, Yuan, Ding, Zhen-Bin, Zhou, Jian, Fan, Jia, Shi, Ying-Hong
Publicado 2020

Nine-factor-based immunohistochemistry classifier predicts recurrence for early-stage hepatocellular carcinoma after curative resection

por Liu, Wei-Ren, Tian, Meng-Xin, Tang, Zheng, Fang, Yuan, Zhou, Yu-Fu, Song, Shu-Shu, Jiang, Xi-Fei, Wang, Han, Tao, Chen-Yang, Zhou, Pei-Yun, Qu, Wei-Feng, Ding, Zhen-Bin, Peng, Yuan-Fei, Zhou, Jian, Fan, Jia, Shi, Ying-Hong
Publicado 2020

Cystathionine β-synthase mediated PRRX2/IL-6/STAT3 inactivation suppresses Tregs infiltration and induces apoptosis to inhibit HCC carcinogenesis

por Zhou, Yu-Fu, Song, Shu-Shu, Tian, Meng-Xin, Tang, Zheng, Wang, Han, Fang, Yuan, Qu, Wei-Feng, Jiang, Xi-Fei, Tao, Chen-Yang, Huang, Run, Zhou, Pei-Yun, Zhu, Shi-Guo, Zhou, Jian, Fan, Jia, Liu, Wei-Ren, Shi, Ying-Hong
Publicado 2021

Exploring pathological signatures for predicting the recurrence of early-stage hepatocellular carcinoma based on deep learning

por Qu, Wei-Feng, Tian, Meng-Xin, Qiu, Jing-Tao, Guo, Yu-Cheng, Tao, Chen-Yang, Liu, Wei-Ren, Tang, Zheng, Qian, Kun, Wang, Zhi-Xun, Li, Xiao-Yu, Hu, Wei-An, Zhou, Jian, Fan, Jia, Zou, Hao, Hou, Ying-Yong, Shi, Ying-Hong
Publicado 2022

A Novel Risk prediction Model for Patients with Combined Hepatocellular-Cholangiocarcinoma

por Tian, Meng-Xin, He, Wen-Jun, Liu, Wei-Ren, Yin, Jia-Cheng, Jin, Lei, Tang, Zheng, Jiang, Xi-Fei, Wang, Han, Zhou, Pei-Yun, Tao, Chen-Yang, Ding, Zhen-Bin, Peng, Yuan-Fei, Dai, Zhi, Qiu, Shuang-Jian, Zhou, Jian, Fan, Jia, Shi, Ying-Hong
Publicado 2018

Development and validation of a prognostic score predicting recurrence in resected combined hepatocellular cholangiocarcinoma

por Tian, Meng-Xin, Luo, Liu-Ping, Liu, Wei-Ren, Deng, Wei, Yin, Jia-Cheng, Jin, Lei, Jiang, Xi-Fei, Zhou, Yu-Fu, Qu, Wei-Feng, Tang, Zheng, Wang, Han, Tao, Chen-Yang, Fang, Yuan, Qiu, Shuang-Jian, Zhou, Jian, Liu, Jing-Feng, Fan, Jia, Shi, Ying-Hong
Publicado 2019

Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study

por Zhu, Gui‐Qi, Liu, Wei‐Ren, Tang, Zheng, Qu, Wei‐Feng, Fang, Yuan, Jiang, Xi‐Fei, Song, Shu‐Shu, Wang, Han, Tao, Chen‐Yang, Zhou, Pei‐Yun, Huang, Run, Gao, Jun, Sun, Hai‐Xiang, Ding, Zhen‐Bin, Peng, Yuan‐Fei, Dai, Zhi, Zhou, Jian, Fan, Jia, Shi, Ying‐Hong
Publicado 2021

Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma

por Tian, Meng-Xin, Liu, Wei-Ren, Wang, Han, Zhou, Yu-Fu, Jin, Lei, Jiang, Xi-Fei, Tao, Chen-Yang, Tang, Zheng, Zhou, Pei-Yun, Fang, Yuan, Qu, Wei-Feng, Ding, Zhen-Bin, Peng, Yuan-Fei, Dai, Zhi, Qiu, Shuang-Jian, Zhou, Jian, Lau, Wan Yee, Fan, Jia, Shi, Ying-Hong
Publicado 2019

Age-adjusted Charlson Comorbidity Index predicts survival in intrahepatic cholangiocarcinoma patients after curative resection

por Qu, Wei-Feng, Zhou, Pei-Yun, Liu, Wei-Ren, Tian, Meng-Xin, Jin, Lei, Jiang, Xi-Fei, Wang, Han, Tao, Chen-Yang, Fang, Yuan, Zhou, Yu-Fu, Song, Shu-Shu, Ding, Zhen-Bin, Peng, Yuan-Fei, Dai, Zhi, Qiu, Shuang-Jian, Zhou, Jian, Fan, Jia, Tang, Zheng, Shi, Ying-Hong
Publicado 2020

CD36(+) cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor

por Zhu, Gui-Qi, Tang, Zheng, Huang, Run, Qu, Wei-Feng, Fang, Yuan, Yang, Rui, Tao, Chen-Yang, Gao, Jun, Wu, Xiao-Ling, Sun, Hai-Xiang, Zhou, Yu-Fu, Song, Shu-Shu, Ding, Zhen-Bin, Dai, Zhi, Zhou, Jian, Ye, Dan, Wu, Duo-Jiao, Liu, Wei-Ren, Fan, Jia, Shi, Ying-Hong
Publicado 2023

Conversion therapy for initially unresectable hepatocellular carcinoma using a combination of toripalimab, lenvatinib plus TACE: real-world study

por Qu, Wei-Feng, Ding, Zhen-Bin, Qu, Xu-Dong, Tang, Zheng, Zhu, Gui-Qi, Fu, Xiu-Tao, Zhang, Zi-Han, Zhang, Xin, Huang, Ao, Tang, Min, Tian, Meng-Xin, Jiang, Xi-Fei, Huang, Run, Tao, Chen-Yang, Fang, Yuan, Gao, Jun, Wu, Xiao-Ling, Zhou, Jian, Fan, Jia, Liu, Wei-Ren, Shi, Ying-Hong
Publicado 2022

Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation

por Qu, Wei-Feng, Tian, Meng-Xin, Lu, Hong-Wei, Zhou, Yu-Fu, Liu, Wei-Ren, Tang, Zheng, Yao, Zhao, Huang, Run, Zhu, Gui-Qi, Jiang, Xi-Fei, Tao, Chen-Yang, Fang, Yuan, Gao, Jun, Wu, Xiao-Ling, Chen, Jia-Feng, Zhao, Qian-Fu, Yang, Rui, Chu, Tian-Hao, Zhou, Jian, Fan, Jia, Yu, Jin-Hua, Shi, Ying-Hong
Publicado 2023

Single-cell and spatial architecture of primary liver cancer

por Zhou, Pei-Yun, Zhou, Cheng, Gan, Wei, Tang, Zheng, Sun, Bao-Ye, Huang, Jin-Long, Liu, Gao, Liu, Wei-Ren, Tian, Meng-Xin, Jiang, Xi-Fei, Wang, Han, Tao, Chen-Yang, Fang, Yuan, Qu, Wei-Feng, Huang, Run, Zhu, Gui-Qi, Huang, Cheng, Fu, Xiu-Tao, Ding, Zhen-Bin, Gao, Qiang, Zhou, Jian, Shi, Ying-Hong, Yi, Yong, Fan, Jia, Qiu, Shuang-Jian
Publicado 2023

Daily decrease of post-operative alpha-fetoprotein by 9% discriminates prognosis of HCC: A multicenter retrospective study

por Zhou, Pei-Yun, Yang, Chao-Ping, Tang, Zheng, Yi, Yong, Liu, Wei-Ren, Tian, Meng-Xin, Huang, Jin-Long, Gan, Wei, Jiang, Xi-Fei, Liu, Gao, Wang, Han, Tao, Chen-Yang, Fang, Yuan, Qu, Wei-Feng, Zhou, Cheng, Guan, Ruo-Yu, Sun, Bao-Ye, Zhou, Yu-Fu, Song, Shu-Shu, Ding, Zhen-Bin, Peng, Yuan-Fei, Dai, Zhi, Zhou, Jian, Fan, Jia, Gong, Guo-Zhong, Shi, Ying-Hong, Qiu, Shuang-Jian
Publicado 2019